Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. N-diethylmethylammoniummethyl-p-(2-(n-octyloxy)benzoyl)aminobenzoate Bromide
2. Octylonium
3. Octylonium Bromide
4. Octylonium Iodide
5. Spasmomen
1. 26095-59-0
2. Octylonium Bromide
3. Otilonium (bromide)
4. Sp63
5. Doralin
6. Spasmoctyl 40
7. 21hn3n72pv
8. Spasmomen
9. Sp-63
10. Otilonium Bromide (inn)
11. Diethyl(2-hydroxyethyl)methylammonium Bromide P-(o-(octyloxy)benzamido)-benzoate
12. Diethyl-methyl-[2-[4-[(2-octoxybenzoyl)amino]benzoyl]oxyethyl]azanium;bromide
13. Dsstox_cid_26357
14. Dsstox_rid_81559
15. Dsstox_gsid_46357
16. Otilonium Bromide [inn]
17. Otilonii Bromidum
18. Ottilonio Bromuro
19. N,n-diethyl-n-methyl-2-(4-(2-(octyloxy)benzamido)benzoyloxy)ethanaminium Bromide
20. Ottilonio Bromuro [italian]
21. Bromure D'otilonium
22. Bromuro De Otilonio
23. Otilonium Bromide [inn:ban]
24. Cas-26095-59-0
25. Otilonii Bromidum [inn-latin]
26. Bromure D'otilonium [inn-french]
27. Bromuro De Otilonio [inn-spanish]
28. Ncgc00163507-01
29. Einecs 247-457-4
30. Unii-21hn3n72pv
31. Octylonium Bromide;sp63
32. Diethyl(2-hydroxyethyl)methylammonium Bromide P-(o-(octyloxy)benzamido)benzoate
33. Ethanaminium, N,n-diethyl-n-methyl-2-((4-((2-(octyloxy)benzoyl)amino)benzoyl)oxy)-, Bromide
34. Mls006011208
35. Schembl109554
36. Otilonium Bromide [mi]
37. Chembl2103773
38. Dtxsid0046357
39. Hy-b0499a
40. Otilonium Bromide [mart.]
41. Hms3651l16
42. Hms3885i05
43. Otilonium Bromide [who-dd]
44. Bcp09737
45. Tox21_112059
46. Mfcd00211142
47. Otilonium Bromide, >=98% (hplc)
48. S3047
49. Akos015833077
50. Tox21_112059_1
51. Ccg-270064
52. Ks-1278
53. Ammonium, Diethyl(2-hydroxyethyl)methyl-, Bromide, P-(o-(octyloxy)benzamido)benzoate
54. N,n-diethyl-n-methyl-2-((4-(2-(octyloxy)benzamido)benzoyl)oxy)ethan-1-aminium Bromide
55. N,n-diethyl-n-methyl-2-((4-(2-(octyloxy)benzamido)benzoyl)oxy)ethanaminium Bromide
56. Ncgc00163507-03
57. Ethanaminium, N,n-diethyl-n-methyl-2-[[4-[[2-(octyloxy)benzoyl]amino]benzoyl]oxy]-, Bromide (1:1)
58. Smr004702974
59. Ft-0630523
60. Sw219209-1
61. D07083
62. Q920900
63. J-016250
64. J-523842
Molecular Weight | 563.6 g/mol |
---|---|
Molecular Formula | C29H43BrN2O4 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 17 |
Exact Mass | 562.24062 g/mol |
Monoisotopic Mass | 562.24062 g/mol |
Topological Polar Surface Area | 64.6 Ų |
Heavy Atom Count | 36 |
Formal Charge | 0 |
Complexity | 600 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Muscarinic Antagonists
Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)
Calcium Channel Blockers
A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)
Gastrointestinal Agents
Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
A03AB06
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
A - Alimentary tract and metabolism
A03 - Drugs for functional gastrointestinal disorders
A03A - Drugs for functional gastrointestinal disorders
A03AB - Synthetic anticholinergics, quaternary ammonium compounds
A03AB06 - Otilonium bromide
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25283
Submission : 2011-08-31
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40113
Submission : 2024-06-28
Status : Active
Type : II
Date of Issue : 2022-10-21
Valid Till : 2025-09-11
Written Confirmation Number : WC-0451
Address of the Firm : Survey No. 163, 163/A & 164/A, Vill. Pittampally, Nalgonda-508114, Telangana, In...
Date of Issue : 2022-11-04
Valid Till : 2025-07-02
Written Confirmation Number : WC-0080
Address of the Firm : Plot No. 5/1-B, G.I.D.C Estate, Ankleshwar, Dist. Bharuch-393002, Gujarat, India
Registrant Name : IMCD Korea Co., Ltd.
Registration Date : 2019-03-18
Registration Number : 20190318-209-J-172
Manufacturer Name : Olon SpA
Manufacturer Address : Via Milano, 186 20024 garbagnate Milanese (MI), Italy
Registrant Name : Menarini Korea Co., Ltd.
Registration Date : 2021-06-11
Registration Number : 20210611-209-J-1023
Manufacturer Name : Olon SpA
Manufacturer Address : Via Livelli, 1-26852 Casaletto Lodigiano fraz.Mairano (LO)-Italy
NDC Package Code : 66022-0305
Start Marketing Date : 2024-06-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
About the Company : Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse the...
About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
Zhejiang Hengkang Pharm Group is a dynamic pharmaceutical entity, spanning drug research, large-scale production, and global marketing.
About the Company : Established in 2004 and headquartered in Hangzhou, Hengkang established multiple factories, research and sales centers in Zhejiang, Shandong, and Henan. With facilities conforming ...
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
About the Company : Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opp...
About the Company : Axyntis Group, founded in 2007, is France’s leading independent multi-site player in fine chemicals with a €90 million annual turnover. Axyntis has become a key producer of API...
About the Company : Established in 2011 and situated in Hangzhou, Zhejiang, China, Hangzhou Longshine Bio-Tech CO., Ltd is dedicated to providing services for pharmaceutical and chemical products, cat...
About the Company : Public health is always an imperative that implies immense responsibility, not a mere re-adjustable option. As a company operating under world’s second largest industry of Pharma...
About the Company : We produce Active Pharmaceutical Ingredients (APIs) providing integrated full-service capabilities. Olon’s ability to develop and manufacture Active Pharmaceutical Ingredients (...
About the Company : Symed Labs Ltd is a leading Hyderabad based manufacturer of Active Pharmaceutical Ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry for chemist...
About the Company : Viyash, true to its name, literally represents honesty and leadership in every sense. We are an integrated pharmaceutical company with a strong portfolio of niche formulations, ...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info : Generic
Registration Country : Turkey
Brand Name : Nospazm
Dosage Form : Film Coated Tablet
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Turkey
Regulatory Info :
Registration Country : Italy
Brand Name : Spasmomen 40
Dosage Form :
Dosage Strength : 30 Conf 40 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Somatic Spasmomen 40
Dosage Form :
Dosage Strength : 30 Cpr 40 Mg + 2 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Somatic Spasmomen
Dosage Form :
Dosage Strength : 30 Conf 20 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Spasen 40
Dosage Form :
Dosage Strength : 30 Cpr Riv 40 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Somatic Spasen 40
Dosage Form :
Dosage Strength : 30 Cpr Riv 40 Mg + 2 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
36
PharmaCompass offers a list of Otilonium Bromide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Otilonium Bromide manufacturer or Otilonium Bromide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Otilonium Bromide manufacturer or Otilonium Bromide supplier.
PharmaCompass also assists you with knowing the Otilonium Bromide API Price utilized in the formulation of products. Otilonium Bromide API Price is not always fixed or binding as the Otilonium Bromide Price is obtained through a variety of data sources. The Otilonium Bromide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Otilonium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Otilonium, including repackagers and relabelers. The FDA regulates Otilonium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Otilonium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Otilonium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Otilonium supplier is an individual or a company that provides Otilonium active pharmaceutical ingredient (API) or Otilonium finished formulations upon request. The Otilonium suppliers may include Otilonium API manufacturers, exporters, distributors and traders.
click here to find a list of Otilonium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Otilonium DMF (Drug Master File) is a document detailing the whole manufacturing process of Otilonium active pharmaceutical ingredient (API) in detail. Different forms of Otilonium DMFs exist exist since differing nations have different regulations, such as Otilonium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Otilonium DMF submitted to regulatory agencies in the US is known as a USDMF. Otilonium USDMF includes data on Otilonium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Otilonium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Otilonium suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Otilonium Drug Master File in Korea (Otilonium KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Otilonium. The MFDS reviews the Otilonium KDMF as part of the drug registration process and uses the information provided in the Otilonium KDMF to evaluate the safety and efficacy of the drug.
After submitting a Otilonium KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Otilonium API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Otilonium suppliers with KDMF on PharmaCompass.
A Otilonium written confirmation (Otilonium WC) is an official document issued by a regulatory agency to a Otilonium manufacturer, verifying that the manufacturing facility of a Otilonium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Otilonium APIs or Otilonium finished pharmaceutical products to another nation, regulatory agencies frequently require a Otilonium WC (written confirmation) as part of the regulatory process.
click here to find a list of Otilonium suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Otilonium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Otilonium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Otilonium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Otilonium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Otilonium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Otilonium suppliers with NDC on PharmaCompass.
Otilonium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Otilonium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Otilonium GMP manufacturer or Otilonium GMP API supplier for your needs.
A Otilonium CoA (Certificate of Analysis) is a formal document that attests to Otilonium's compliance with Otilonium specifications and serves as a tool for batch-level quality control.
Otilonium CoA mostly includes findings from lab analyses of a specific batch. For each Otilonium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Otilonium may be tested according to a variety of international standards, such as European Pharmacopoeia (Otilonium EP), Otilonium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Otilonium USP).